Cargando…

Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin

Exosome–liposome hybrid nanocarriers containing chemotherapeutic agents have been developed to enhance drug delivery, improve the efficacy of the treatment of metastatic cancer, and overcome chemoresistance in cancer therapy. Thus, the objectives of this study were to investigate the toxicological p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Eliza Rocha, Souza, Fernanda Rezende, Cassali, Geovanni Dantas, Sabino, Adriano de Paula, de Barros, André Luis Branco, Oliveira, Mônica Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696811/ https://www.ncbi.nlm.nih.gov/pubmed/36365075 http://dx.doi.org/10.3390/pharmaceutics14112256

Ejemplares similares

Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines
por: Duarte, Jaqueline Aparecida, et al.
Publicado: (2023)

Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
por: de Oliveira Silva, Juliana, et al.
Publicado: (2019)

PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
por: Nunes, Shirleide Santos, et al.
Publicado: (2022)

Cisplatin-Loaded Thermosensitive Liposomes Functionalized with Hyaluronic Acid: Cytotoxicity and In Vivo Acute Toxicity Evaluation
por: Gomes, Isabela Pereira, et al.
Publicado: (2023)

pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment
por: Nunes, Shirleide Santos, et al.
Publicado: (2021)

Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity
por: Leite, Elaine A, et al.
Publicado: (2012)

HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland
por: Damasceno, Karine Araújo, et al.
Publicado: (2016)

Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma
por: Rocha, Talita Guieiro Ribeiro, et al.
Publicado: (2016)

Comparative mammary oncology: canine model
por: Cassali, Geovanni Dantas
Publicado: (2013)

Irinotecan-Loaded Polymeric Micelles as a Promising Alternative to Enhance Antitumor Efficacy in Colorectal Cancer Therapy
por: Campos, Fernanda Lapa, et al.
Publicado: (2022)

Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model
por: Mendes Miranda, Sued Eustáquio, et al.
Publicado: (2021)

Morphological Aspects and Immunophenotypic Profiles of Mammary Carcinomas in Benign-Mixed Tumors of Female Dogs
por: Ribeiro, Gustavo Meirelles, et al.
Publicado: (2012)

Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity
por: Wang, Wenxi, et al.
Publicado: (2017)

Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin
por: Hekmatirad, Shirin, et al.
Publicado: (2021)

Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)

Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia
por: Moreira-Barros, Joana, et al.
Publicado: (2018)

Mixed tumors of the canine mammary glands: Evaluation of prognostic factors, treatment, and overall survival
por: Nunes, Fernanda Camargo, et al.
Publicado: (2018)

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy
por: Yang, Yang, et al.
Publicado: (2023)

Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice
por: Takayama, Takuma, et al.
Publicado: (2020)

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing
por: Ngoune, Romeo, et al.
Publicado: (2018)

COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology
por: Vieira, Thaynan Cunha, et al.
Publicado: (2022)

Secretory carcinoma of the canine mammary gland with nodal and bone metastases: Case report
por: Silva, Halana do Carmo, et al.
Publicado: (2022)

Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment
por: Coelho, Larissa D., et al.
Publicado: (2023)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Neuroendocrine Carcinomas of the Canine Mammary Gland: Histopathological and Immunohistochemical Characteristics
por: Nakagaki, Karen Yumi Ribeiro, et al.
Publicado: (2021)

CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
por: Soleimani, Anvar, et al.
Publicado: (2022)

Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives
por: Ribeiro, Beatriz C., et al.
Publicado: (2022)

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer
por: Wu, Sheng-Kai, et al.
Publicado: (2014)

Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model
por: Maswadeh, Hamzah M, et al.
Publicado: (2015)

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
por: Wang, Chao, et al.
Publicado: (2015)

Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
por: Yokoe, Inoru, et al.
Publicado: (2021)

Canine Mammary Mixed Tumours: A Review
por: Dantas Cassali, Geovanni, et al.
Publicado: (2012)

Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Liposomal doxorubicin-induced palmoplantar erythrodysthesia syndrome
por: Yadav, Nidhi, et al.
Publicado: (2015)

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
por: Mehn, Dora, et al.
Publicado: (2017)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kttqf37nqmqu56accsj2ei17ef